Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Long-term Durability of Middle Lobe Only (MLO) Versus Complete Trans-Urethral Vaporization of the Prostate (PVP), Prospective Cohort Study.

NCT04529369 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT04529369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Long-term Durability of Middle Lobe Only (MLO) Versus Complete Trans-Urethral Vaporization of the Prostate (PVP), Prospective Cohort Study.
Lead sponsor
Jewish General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2020
Completion date
October 31, 2030
Enrollment
280 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia